Symbol
Amylyx Pharmaceuticals, Inc.
Full name of the company.
MEDICAL-DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$3.43
Current price of the stock
$914K
Trading volume of the stock
$233.6M
Market capitalization of the company
Micro Cap
Category of market capitalization
65.00%
Long-term growth mean estimate
3.86
Mean analyst rating
113.79%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
4.55
Current ratio
-94.47%
Gross profit margin
-18187.74%
Operating profit margin
-18187.74%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-17476.92%
Pretax profit margin
-17476.92%
Net profit margin
-37.06%
Measures profitability relative to shareholders' equity
-37.06%
ROE excluding intangible assets
-29.00%
Measures profitability relative to total assets
-37.06%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
0.24
Receivables turnover ratio
374.50
Average number of days it takes to collect receivables
-0.90
Measures valuation relative to earnings
-1.99
P/E based on future earnings estimates
1.19
Measures valuation relative to sales
1.20
Measures valuation relative to book value
-1.42
Measures valuation relative to operating cash flow
-1.15
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
